1Yoh W, Astrid HS, Asad U, et al. Complementation of an hMSH2 defect in human colorectal carcinoma cells by human chromosome 2 transfer [J]. Molecular Carcinogenesis, 2000,29:37.
2Fishel R, Lesco MK, Rao, MRS. The human Mutator Gene Homolog MSH2 and its association with Hereditary Nonpo-lyposis Colon Cancer [J]. Cell,1993,75:1027.
3Kolodner RD, Hall NR, Lipford J, et al. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations [J]. Genomics, 1994,24(3):516.
4Wada C, Shionoya S, Fujino Y, et al. Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia[J]. Blood,1994,83(12):3449.
6Starostik P, Mansgouri T, O'BrienS, et al. Deficiency of the ATM protein expression defines and aggressive subgroup of B-cell chronic lymphocytic leukemia [J]. Cancer Res,1998,58(20):4552.
7Nozawa H, Oda E, Ueda S, et al. Functionally inattivating point mutation in the tumor-supressor IRF-1 gene identified in human gastric cancer[J]. Int J Cancer, 1998,77:522.
8Bashirova AA, Markelov MI, Shlykova TV, et al. The human RIL gene: mapping to human chromosome 5q31.1,genomic organization and alternative transcripts[J]. Gene, 1998,210:239.
9Heijlik DP, Kottickal LV,Liang H, et al. Localization of SMAD5 and its evaluation as a candidate myeloid tumor surpressor[J]. Cancer Res, 1997,57:3779.
10Ellenson LH. hMLH1 promoror hypermethylation in microsatellite instability-positive endometrial carcinoma. Cause or consequence[J]?Am J Pathol, 1999,155:1399.
1JACOB S, PRAZ F. DNA mismatch repair defects: role in coloreetal carcinogenesis[J]. Biochimie, 2002,84 (1) : 27-47.
2APADOULOS N, LINDBLOM A. Molecular basis of HNPCC= mutations of MMR genes[J]. Hum Mutat, 1997,10 (2) ,89- 99.
3ARAI T, KASAHARA I, SAWABE M, et al. Role of methy- lation o{ the hMLH1 gene promoter in the development o{ gas tric and colorectal carcinoma in the elderly[J]. Geriatr Geron- tol Int, 2010,10(Suppl 1) : $207-$212.
4KULKE M H, THAKORE K S, THOMAS G, et al. Micro- satellite instability and hMLH1/hMSH2 expression in Barrett esophagus-associated adenoeareinoma [J]. Cancer, 2001, 91 (8) : 1451-1457.
5FLANAGAN S, KROKOSKY C M, MANNAVA S, et al. MLH1 deficiency enhances radiosensitization with 5-fluorode- oxyuridine by increasing DNA mismatches[J]. Mol Pharma- col, 2008,74(3) :863-871.
6LYNCH H T, WATSON P, SHAW T G, et al. Clinical im- pact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part II : Hereditary nonpo- lyposis colorectal carcinoma as a model[J]. Cancer, 1999,86 (11 Suppl) ..2457-2463.
7LEE H J, JANG Y J, LEE E J, et al. The significance of mis- match repair genes in gastric cancer[J]. J Cancer Res Ther, 2013,9(1) : 80-83.
8MOGHBELI M, MOAVEN O, MEMAR B, et al. Role of hMLH1 and E-cadherin promoter methyiation in gastric cancer progression[J]. J Gastrointest Cancer, 2014,45 (1) : 40- 47.
9GRAS E, CATASUS L, ARGUELLES R, et al. Microsatel- lite instability, MLH-1 promoter hypermethylation, and fra- meshift mutations at coding mononucleotide repeat microsatel-lites in ovarian tumors[J]. Cancer, 2001,92(11) :2829-2836.
10YOSHIKAWA H. DNA methylation and cancer[J]. Gan To Kagaku Ryoho, 2007,34 : 145-149.
